Mortality rates and risk factors for asymptomatic deep vein thrombosis in medical patients

Paul T. Vaitkus; Alain Leizorovicz; Alexander T. Cohen; Alexander G. G. Turpie; Carl-Gustav Olsson; Samuel Z. Goldhaber; for the PREVENT Medical Thromboprophylaxis Study Group

doi:10.1160/TH04-05-0323

Thrombosis and Haemostasis, Table of Contents

Thromb Haemost 2005; 93(01): 76-79
DOI: 10.1160/TH04-05-0323

Blood Coagulation, Fibrinolysis and Cellular Haemostasis

Schattauer GmbH

Mortality rates and risk factors for asymptomatic deep vein thrombosis in medical patients

Paul T. Vaitkus

¹Cardiology Division, College of Medicine, University of Illinois at Chicago, Chicago, Illinois, USA and Clinical Research and Development, Pharmacia, Skokie, Illinois, USA

,

Alain Leizorovicz

²Unité de Pharmacologie Clinique, EA 643, Université Claude Bernard Lyon I, Lyon, France

,

Alexander T. Cohen

³Department of Academic Medicine, Guy’s, King’s and St Thomas’ School of Medicine, London, UK

,

Alexander G. G. Turpie

⁴Department of Medicine, Hamilton Health Sciences – General Hospital, Hamilton, Ontario, Canada

,

Carl-Gustav Olsson

⁵Verksamhetsområde Akutsjukvård, Universitetssjukhuset, Lund, Sweden Harvard Medical School, Boston, Massachusetts, USA

,

Samuel Z. Goldhaber

⁶Cardiovascular Division, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts, USA

,

for the PREVENT Medical Thromboprophylaxis Study Group

› Author Affiliations

Abstract

Full Text

PDF Download

Keywords

Venous embolism - deep vein thrombosis - proximal - prevention - dalteparin

References

References
1 Geerts WH, Heit JA, Clagett GP. et al Prevention of venous thromboembolism. Chest 2001; 119 (Suppl. 01) 132S-75S.
2 Haas SK. Venous thromboembolic risk and its prevention in hospitalized medical patients. Semin Thromb Hemost 2002; 28: 577-84.
3 Hyers TM, Agnelli G, Hull RD. et al Antithrombotic therapy for venous thromboembolic disease. Chest 2001; 119 (Suppl. 01) 176S-93S.
4 Kakkar VV, Howe CT, Flanc C. et al Natural history of postoperative deep-vein thrombosis. Lancet 1969; 2: 230-2.
5 Meignan M, Rosso J, Gauthier H. et al Systematic lung scans reveal a high frequency of silent pulmonary embolism in patients with proximal deep venous thrombosis. Arch Intern Med 2000; 160: 159-64.
6 Kearon C. Natural history of venous thromboembolism. Circulation 2003; 107 (23) (Suppl. 01) I22-30.
7 Moser KM, LeMoine JR. Is embolic risk conditioned by location of deep venous thrombosis?. Ann Intern Med 1981; 94 4 Pt 1 439-44.
8 Monreal M, Ruiz J, Fraile M. et al Prospective study on the usefulness of lung scan in patients with deep vein thrombosis of the lower limbs. Thromb Haemost 2001; 85: 771-4.
9 Girard P, Decousus M, Laporte S. et al Diagnosis of pulmonary embolism in patients with proximal deep vein thrombosis: specificity of symptoms and perfusion defects at baseline and during anticoagulant therapy. Am J Respir Crit Care Med 2001; 164: 1033-7.
10 Vaitkus PT, Leizorovicz A, Goldhaber SZ. Rationale and design of a clinical trial of a low-molecular- weight heparin in preventing clinically important venous thromboembolism in medical patients: the prospective evaluation of dalteparin efficacy for prevention of venous thromboembolism in immobilized patients trial (the PREVENT study). Vasc Med 2002; 7: 269-73.
11 Leizorovicz A, Cohen AT, Turpie AGG. et al A randomized, placebo-controlled trial of dalteparin for the prevention of venous thromboembolism in acutely ill medical patients. Circulation 2004; 110: 874-9.
12 Decousus H, Leizorovicz A, Parent F. et al A clinical trial of vena caval filters in the prevention of pulmonary embolism in patients with proximal deep-vein thrombosis. N Engl J Med 1998; 338: 409-15.
13 Goldhaber SZ, Visani L, De Rosa M. Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER). Lancet 1999; 353: 1386-9.
14 Kearon C, Julian JA, Newman TE. et al Noninvasive diagnosis of deep venous thrombosis. McMaster Diagnostic Imaging Practice Guidelines Initiative. Ann Intern Med 1998; 128: 663-7.